Publication | Open Access
Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients
106
Citations
12
References
2019
Year
Cell proliferation is potentially a new biomarker of response to ICIs in NSCLC and is applicable to PD-L1 negative tumors.
| Year | Citations | |
|---|---|---|
Page 1
Page 1